Microba Life Sciences Limited
ASX:MAP.AX
Overview | Financials
Company Name | Microba Life Sciences Limited |
Symbol | MAP.AX |
Currency | AUD |
Price | 0.18 |
Market Cap | 80,613,360 |
Dividend Yield | 0% |
52-week-range | 0.145 - 0.23 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Dr. Luke Reid |
Website | https://microba.com |
An error occurred while fetching data.
About Microba Life Sciences Limited
Microba Life Sciences Limited provides microbiome testing and analysis services for clinicians, consumers, and research customers in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, and the United States. It offers pathology, therapeutics, and diagnostics services based on the human gut microbiome; Databank, for discovery of therapeutic
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD